Perhaps not entirely unjustified comment. However, they now have funds and Astra internal review now underway and the glimmer of hope on commercial sales. Medical systems are under pressure to cut costs and anything in the lifecycle of medical treatments will be viewed favorably IMO. This is one such possibility amongst many
Ann: Application for quotation of securities - LBT, page-6
Add LBT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.8¢ |
Change
0.001(5.88%) |
Mkt cap ! $33.23M | |||
| Open | High | Low | Value | Volume |
| 1.8¢ | 1.9¢ | 1.8¢ | $18.12K | 1.002M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 1496138 | 1.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.9¢ | 811192 | 4 |
View Market Depth
| Last trade - 11.00am 02/10/2024 (20 minute delay) ? |
| LBT (ASX) Chart |